Received Apr 15, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 72M4D | IM / RL |
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37KF3 | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | Z007712 | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | MM0530 | IM / LL |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 94A7Z | PO / MO |
Patient received first dose of rotavirus after the recommended age of 15 weeks, 0 days. No known signs of intussuception following administration
No known medication history
No known allergies